SCTX·US

Scribe Therapeutics

Scribe Therapeutics is a genetic-medicines biotechnology company developing engineered CRISPR genome- and epigenome-editing platforms based on CasX. It generates commercial value through technology licensing and partnered development programs with pharmaceutical companies, while advancing its own investigational gene-editing therapeutics.

Create free account

Thematic Position

SCTX

Healthcare Innovation

Gene Therapy & EditingLeader

Relationship Groups

Partners2

Licensing1

Competitors7

Relationship details are part of the Pro plan.

Recent Discoveries

Recent discoveries are part of the Pro plan.

Management Perspective on Regulatory & Geopolitical Developments

export controlsanctionembargo

U.S. export controls and sanctions may restrict supply of product candidates to certain countries

SEC 10-QSep 2, 2026

The full regulatory passage is part of the Pro plan.